NRX Pharmaceuticals (NRXP) Earnings
NRX Pharmaceuticals's next earnings report is expected on Friday, November 13, 2026, with EPS expected around -0.29.
Summary
In the quarter ended June 2026, NRX Pharmaceuticals had revenue of $1M, and diluted EPS of -0.44.
On August 14, 2026 it reported EPS of -0.18 against an estimate of -0.09 (missed).
Report dates
| Report | Date | Time | EPS estimate | EPS reported | Result |
|---|---|---|---|---|---|
| Next | Fri Nov 13, 2026 | — | -0.29 | — | — |
| Last | Fri Aug 14, 2026 | — | -0.09 | -0.18 | Missed |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Also reporting the week of November 9
| Company | Date | Time |
|---|---|---|
| Berkshire Hathaway Inc BRK-B | Mon Nov 9 | Reported |
| Cisco Systems Inc CSCO | Thu Nov 12 | After close |
| Applied Materials Inc AMAT | Thu Nov 12 | After close |
| Brookfield Corp BN | Thu Nov 12 | Before open |
| Constellation Energy Corp CEG | Mon Nov 9 | Reported |
| KKR & Co. Inc. KKR | Mon Nov 9 | Reported |
| Barrick Mining Corporation B | Mon Nov 9 | Reported |
| Petroleo Brasileiro Petrobras SA ADR PBR | Tue Nov 10 | After close |
Quarterly results
The last 12 quarters from NRX Pharmaceuticals's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | $1M | — | -0.44 | — | -590.8% | 2026-08-14 |
| Mar 31, 2026 | $1M | — | -0.04 | — | -444.0% | 2026-05-15 |
| Dec 31, 2025 | $983,000 | — | — | — | -470.4% | 2026-03-23 |
| Sep 30, 2025 | $242,000 | — | -0.27 | — | -1662.8% | 2025-11-14 |
| Jun 30, 2025 | $0 | — | -0.98 | — | — | 2025-08-18 |
| Mar 31, 2025 | $0 | — | -0.34 | — | — | 2025-05-15 |
| Dec 31, 2024 | $0 | — | — | — | — | 2025-03-14 |
| Sep 30, 2024 | $0 | — | -0.15 | — | — | 2024-11-14 |
| Jun 30, 2024 | — | — | -0.75 | — | — | 2024-08-14 |
| Mar 31, 2024 | — | — | -0.74 | — | — | 2024-05-14 |
| Dec 31, 2023 | — | — | — | — | — | 2024-03-29 |
| Sep 30, 2023 | — | — | -0.70 | — | — | 2023-11-14 |
Questions about NRX Pharmaceuticals
When does NRX Pharmaceuticals report earnings?
NRX Pharmaceuticals's next earnings report is expected on November 13, 2026.
Did NRX Pharmaceuticals beat earnings estimates?
In its report on August 14, 2026, NRX Pharmaceuticals missed the EPS estimate: -0.18 reported against -0.09 expected.
How did NRX Pharmaceuticals do last quarter?
In the quarter ended June 2026, NRX Pharmaceuticals had revenue of $1M, and diluted EPS of -0.44.
From NRX Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.